Skip to main content

Find Clinical Trials

Home
Conditions
Immunotherapy

Clinical trial condition

Immunotherapy

Explore clinical trials studying Immunotherapy. Study availability and eligibility vary by location and protocol.

216 public trials 103 recruiting studies

Refine in advanced search Browse all conditions

Immunotherapy trial results

Recruiting

Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases

NCT06702826

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +17 more
Locations: Xiangya Hospital, Central South University Changsha, Hunan, China

View Trial Details

Recruiting

bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC

NCT06061276

Conditions: Adenocarcinoma, Camrelizumab, Carcinoma, +12 more
Locations: Sun Yat-sen University Cancer Center Guanzhou, Guangdong, China

View Trial Details

Recruiting

68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.

NCT06608160

Conditions: Immunotherapy, Lung Carcinoma, Lung Diseases, +7 more
Locations: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC

NCT06510660

Conditions: Biomarkers, Carcinoma, Carcinoma, Squamous Cell, +14 more
Locations: Fujian Medical University Union Hospital Fuzhou, Fujian, China

View Trial Details

Recruiting

Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular Carcinoma

NCT06571396

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Qilu hospital of Shandong university Jinan, Shandong, China

View Trial Details

Recruiting

bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma

NCT06070636

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma

NCT06413342

Conditions: Chemoradiotherapy, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations: Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Nutrition Impact on Immunotherapy of Cancer

NCT06500234

Conditions: Cancer, Immunotherapy, Neoplasms, +7 more
Locations: Qingdao Central Hospital Qingdao, Shandong, China

View Trial Details

Recruiting

Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC)

NCT04278222

Conditions: Anlotinib, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: Department of Medical Oncology, Shanghai Changzheng Hospital Shanghai, China

View Trial Details

Recruiting

GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers

NCT03198052

Conditions: CAR-T Cell, Cancer, Immunotherapy, +8 more
Locations: The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China

View Trial Details